| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212933 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 30 Pages |
Abstract
The present retrospective consecutive cohort study showed improved OS with our current protocol (P3; high-dose IMRT with concurrent high-dose cisplatin) compared with historical protocols. The outcomes for patients with CEC remain poor, and novel approaches to improve the therapeutic ratio are warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Lachlan J. MBBS, Shao Hui MRT(T), MD, MSc, Wei PhD, Jiahua MMath, Rebecca K.S. MBChB, MSc, James MD, John MD, Bernard MD, John MD, Andrew MD, Aaron MBBS (Hons), Ian MD, Jolie MD,